Singapore: Mr Chris Fullerton, chairman of Australian firm Bionomics, will retire from the board of Bionomics, effective...
Singapore: Agenix has entered an agreement with Tyrian Diagnostics to license its rapid point-of-care human diagnostic ...
Singapore: Australia-based QRxPharma is proceeding with US FDA to discuss the company's Moxduo new drug application (NDA...
Singapore: According to a latest study published online in Neurology, omega-3 fatty acids, like those found in Omega XL ...
Singapore: Agilent Technologies extended its collaboration with the University of Sydney, Australia, by providing advanc...
Singapore: PolyActiva raised $9.53 million (AUD $9.2 million) in a Series B financing round from a consortium of investo...
Singapore: ElectroCore's GammaCore therapy has been approved for commercial sale by the Therapeutic Goods Administratio...
Singapore: Sigma Pharmaceuticals has agreed to sell its over-the-counter and pharmaceutical divisions to Aspen Global. U...
Singapore: In a release issued last week, the peak body concerned with the disease warned that Australia already has an ...
Singapore: GSK is working with the Therapeutic Goods Administration (TGA) to voluntarily recall for quality reasons six...
Singapore: At the AIDS 2014 Conference in Melbourne, Australia, scientists declared that they had identified a biomarker...
Singapore: Patrys released additional data from the first cohort of multiple myeloma patients treated with PAT-SM6 in th...
Singapore: Australian company Linear Clinical Research has won the Emerging Exporter of the year Award at the 50th annua...
Singapore: Clinuvel Pharmaceuticals commenced its confirmatory phase III clinical trial of its novel drug SCENESSE (afam...
Phylogica, a leading peptide drug discovery company based in Australia, has developed a world-class drug discovery platf...
Singapore: Specialty pharmaceutical company Hatchtech successfully completed end-of-phase II (EOP2) consultations with t...
Singapore: Senz Oncology announced that the ï¬rst patient has commenced treatment in a phase I/II clinical evaluati...
Singapore: Resverlogix has initiated an exploratory phase II clinical trial in patients with pre-diabetes mellitus to e...
